期刊文献+

益气活血通脉汤联合西药治疗冠心病心绞痛的效果分析 被引量:5

Effect of Yiqi Huoxue Tongmai decoction combined with western medicine on angina pectoris of coronary heart disease
下载PDF
导出
摘要 目的:探讨益气活血通脉汤联合西药治疗冠心病心绞痛的临床效果。方法:选取2013年2月-2017年2月我院收治的冠心病心绞痛患者共计95例,随机抽签分为对照组45例和观察组50例。对照组给予常规西药治疗,观察组联合给予益气活血通脉汤治疗,比较患者的临床治疗总有效率,统计药物不良反应发生率。结果:观察组患者的不良反应发生率低于对照组(P<0.05),HDL-C水平高于对照组(P<0.05);观察组患者的临床治疗总有效率明显高于对照组(P<0.05)。结论:益气活血通脉汤联合西药治疗冠心病心绞痛能提高临床疗效,且不良反应小,具有积极的推广意义。 Objective:To investigate the clinical effect of Yiqi Huoxue Tongmai Decoction(益气活血通脉汤)combined with western medicine on angina pectoris of coronary heart disease.Methods:95 patients with angina pectoris from February 2013 to February 2017 were randomly divided into the control group 45 cases and the observation group 50 cases.The control group was given conventional western medicine treatment,the observation group was given Yiqi Huoxue Tongmai Decoction treatment,the total effective rate of clinical treatment,statistical incidence of adverse drug reactions were compared.Results:The incidence of adverse reactions in the observation group was lower than that in the control group(P<0.05),and the level of HDL-C was higher than that in the control group(P<0.05).Conclusion:Yiqi Huoxue Tongmai Decoction combined with western medicine could improve the clinical efficacy in the treatment of angina pectoris of coronary heart disease,and it had less side e ffects,which was of positive significance of promotion.
作者 刘星磊 张静 Liu Xinglei;Zhang Jing
出处 《中医临床研究》 2019年第33期31-32,共2页 Clinical Journal Of Chinese Medicine
关键词 冠心病 心绞痛 益气活血通脉汤 中西医结合 疗效 Coronary heart disease Angina pectoris Yiqi Huoxue Tongmai Decoction Integrated traditional Chinese and western medicine Curative effect
  • 相关文献

参考文献6

二级参考文献33

  • 1许继艳,常秀武,丁瑞峰,张丽娟,陈锐.中西医结合治疗60例冠心病心绞痛的疗效观察[J].中国生化药物杂志,2014,34(3):111-113. 被引量:145
  • 2中西医结合防治冠心病、心绞痛、心律失常研究座谈会.冠心病心绞痛疗效评定标准[J].医学研究通讯,1979(12):17.
  • 3邢雁伟,王阶,衷敬柏,李海霞,高永红,何庆勇.采用聚类分析和对应相关方法研究1069例冠心病心绞痛证候应证组合规律[J].中华中医药杂志,2007,22(11):747-750. 被引量:65
  • 4PERSSON G R, PETYERSSON T, OHLSSON O, et al. High-sensitivity serum C-reactive protein levels in subjects with or without myocardial infarction or periodontitis[J].J Clin Periodontol, 2005,32(3) :219.
  • 5GIBBONS R J, ABRAMS J, CHATTERJEE K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-summary article [J].J Am Coil Cardiol, 2003,41(1):159.
  • 6HINGORANI A D, CASAS J P. The intedeukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomization analysis[J]. Lancet, 2012,379(9822): 1214.
  • 7SARRAFZADEGAN N, SADEGHI M, GHAFFARPASAND F, et al. Interleukin-6 in patients with acute coronary syndrome or stable angina pectoris. A comparative study[J]. Herz,2012,37(g) :926.
  • 8POON P Y, SZETO C C, KWAN B C, et al. Relationship between CRP polymorphism and cardiovas-cular events in Chinese peritoneal dialysis patients [J]. Clin J Am Soc Nephrol, 2012,7(2) :304.
  • 9MOURIDSEN M R, INTZILAKIS T, BINICI Z, et al. Prognostic value of high sensitive C-reactive protein in subjects with silent myocardial ischemia[J]. J Electrocardiol, 2012,45(3) :260.
  • 10陈锦鹏,李先任.中西医结合治疗冠心病心绞痛的临床疗效观察[J].中国现代医生,2011,49(14):45-46. 被引量:11

共引文献58

同被引文献41

引证文献5

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部